Cargando…

Potential impact of a modest reduction in salt intake on blood pressure, cardiovascular disease burden and premature mortality: a modelling study

OBJECTIVE: To assess the potential impact of reduction in salt intake on the burden of cardiovascular disease (CVD) and premature mortality in Cameroon. METHODS: Using a multicohort proportional multistate life table model with Markov process, we modelled the impact of WHO’s recommended 30% relative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aminde, Leopold Ndemnge, Cobiac, Linda J, Veerman, J Lennert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Cardiac Risk Factors and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443119/ https://www.ncbi.nlm.nih.gov/pubmed/30997132 http://dx.doi.org/10.1136/openhrt-2018-000943

Ejemplares similares

Cost-effectiveness analysis of population salt reduction interventions to prevent cardiovascular disease in Cameroon: mathematical modelling study
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2020)

Dietary Salt Reduction, Prevalence of Hypertension and Avoidable Burden of Stroke in Vietnam: Modelling the Health and Economic Impacts
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2021)

Avoidable burden of stomach cancer and potential gains in healthy life years from gradual reductions in salt consumption in Vietnam, 2019–2030: a modelling study
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2023)

Estimated Impact of Achieving the Australian National Sodium Reduction Targets on Blood Pressure, Chronic Kidney Disease Burden and Healthcare Costs: A Modelling Study
por: Aminde, Leopold Ndemnge, et al.
Publicado: (2023)

The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Pregnancy complications and premature cardiovascular events among 1.6 million California pregnancies
por: Arnaout, Rima, et al.
Publicado: (2019)

Phosphodiesterase type-5 inhibitor use in type 2 diabetes is associated with a reduction in all-cause mortality
por: Anderson, Simon G, et al.
Publicado: (2016)

Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes
por: Fares, Hassan, et al.
Publicado: (2016)

Midlife blood pressure predicts future diastolic dysfunction independently of blood pressure
por: Ghosh, Arjun Kumar, et al.
Publicado: (2016)

Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
por: Rao, Shishir, et al.
Publicado: (2023)

Effectiveness of an impedance cardiography guided treatment strategy to improve blood pressure control in a real-world setting: results from a pragmatic clinical trial
por: Wang, Luyan, et al.
Publicado: (2021)

Association of ambulatory heart rate and atherosclerosis risk factors with blood pressure in young non-hypertensive adults
por: Cheng, Cynthia, et al.
Publicado: (2016)

Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials
por: Canoy, Dexter, et al.
Publicado: (2022)

Age at period cessation and trajectories of cardiovascular risk factors across mid and later life
por: O'Keeffe, Linda Marie, et al.
Publicado: (2020)

Cardiovascular risk factors and autonomic indices in relation to fatal and non-fatal coronary events
por: Zambach, Christian, et al.
Publicado: (2021)

Blood pressure target achievement and antihypertensive medication use in women and men after first-ever myocardial infarction: the Tromsø Study 1994–2016
por: Hopstock, Laila A, et al.
Publicado: (2018)

Left ventricular longitudinal shortening: relation to stroke volume and ejection fraction in ageing, blood pressure, body size and gender in the HUNT3 study
por: Støylen, Asbjørn, et al.
Publicado: (2020)

Blood pressure self-monitoring practice and associated factors among adult hypertensive patients on follow-up at South Wollo Zone Public Hospitals, Northeast Ethiopia
por: Edmealem, Afework, et al.
Publicado: (2023)

Sex-specific trajectories of molecular cardiometabolic traits from childhood to young adulthood
por: O'Keeffe, Linda M, et al.
Publicado: (2023)

Prerace aspirin to protect susceptible runners from cardiac arrest during marathons: is opportunity knocking?
por: Siegel, Arthur J
Publicado: (2015)

Relationship between altitude and the prevalence of hypertension in Tibet: a systematic review
por: Mingji, Cuomu, et al.
Publicado: (2015)

Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
por: Jørstad, Harald T, et al.
Publicado: (2016)

Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
por: Fuchs, Flávio Danni, et al.
Publicado: (2015)

Association between combat-related traumatic injury and cardiovascular risk
por: Boos, Christopher J, et al.
Publicado: (2022)

Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicity
por: McCarty, Mark F, et al.
Publicado: (2016)

Use of lipid-lowering therapy after ischaemic stroke and expected benefit from intensification of treatment
por: Gynnild, Mari Nordbø, et al.
Publicado: (2022)

Cardiac rehabilitation for heart failure and atrial fibrillation: a propensity- matched study
por: Alhotye, Munyra, et al.
Publicado: (2023)

Agatston score of the descending aorta is independently associated with coronary events in a low-risk population
por: Dudink, Elton A M P, et al.
Publicado: (2018)

Weight change and the risk of incident atrial fibrillation: a systematic review and meta-analysis
por: Jones, Nicholas R, et al.
Publicado: (2019)

Hepatocyte growth factor is associated with greater risk of extracoronary calcification: results from the multiethnic study of atherosclerosis
por: Ogunmoroti, Oluseye, et al.
Publicado: (2022)

Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care
por: Emanuel, G, et al.
Publicado: (2016)

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature
por: DiNicolantonio, James J, et al.
Publicado: (2015)

Capsaicin may have important potential for promoting vascular and metabolic health
por: McCarty, Mark F, et al.
Publicado: (2015)

Childhood and adult exposure to secondhand tobacco smoke and cardiac structure and function: results from Echo-SOL
por: Burroughs Peña, Melissa Suzanne, et al.
Publicado: (2018)

Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UK
por: Tapela, Neo, et al.
Publicado: (2021)

Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease
por: Graham, Fraser J, et al.
Publicado: (2023)

Niacin therapy and the risk of new-onset diabetes: a meta-analysis of randomised controlled trials
por: Goldie, Christina, et al.
Publicado: (2016)

Association between treatment for erectile dysfunction and death or cardiovascular outcomes after myocardial infarction
por: Andersson, Daniel P, et al.
Publicado: (2017)

The impact of passive and active smoking on inflammation, lipid profile and the risk of myocardial infarction
por: Attard, Ritienne, et al.
Publicado: (2017)

Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
por: Parsons, Ruth E, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2j238fkjcudqdsomgk6hpnukbc